Alpheus Medical raised $52M in Series B funding led by HealthQuest Capital and Samsara BioCapital to support a Phase 2B trial for glioblastoma treatment.

May 15, 2025•7 months ago

Amount Raised

$52 Million

Round Type

series b

ChanhassenOther

Investors

Sontag Innovation FundBrain Tumor Investment FundBright EdgeAction Potential Venture CapitaOrbi MedSamsara Bio CapitalHealth Quest Capital

Description

Alpheus Medical, a Chanhassen, MN-based clinical-stage oncology company, raised $52M in Series B funding. The round was led by HealthQuest Capital and Samsara BioCapital. The funds will support a Phase 2B trial for glioblastoma treatment. This innovative therapy selectively targets and destroys cancer cells using ultrasound.

Company Information

Company

Alpheus Medical

Location

1266 Park Road

Chanhassen, Minnesota, United States

About

Alpheus Medical, Inc, is a privately held company based in Oakdale, Minnesota, developing a novel sonodynamic therapy platform targeting solid body cancers. The company’s lead product utilizes a novel, non-invasive drug device combination for outpatient treatment of recurrent glioblastoma multiforme (rGBM). Alpheus Medical’s work has been developed in conjunction with some of the most accomplished names worldwide in neuro-oncology, and with support from the American Cancer Society and National Brain Tumor Society.

Related People

3 contacts

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends